Company Announcements

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Jan. 18, 2023-- Johnson & Johnson (NYSE: JNJ) will participate in the SVB Securities Global Biopharma Conference on Wednesday, February 15^th. Biljana Naumovic, Worldwide Vice President, Oncology and Peter Lebowitz, Global Therapeutic Head, Oncology will represent the Company in a virtual session scheduled at 1:00 p.m. (Eastern Time).

This live audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

The audio webcast replay will be available approximately 48-hrs after the webcast.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230118005064/en/

Investor Contact:
RA-JJCUS-InvestorRel@ITS.JNJ.com

Media Contact:
Jake Sargent (732) 524-1090

Source: Johnson & Johnson